Elsevier

International Immunopharmacology

Volume 43, February 2017, Pages 203-209
International Immunopharmacology

The NLRP3 inflammasome is a potential target of ozone therapy aiming to ease chronic renal inflammation in chronic kidney disease

https://doi.org/10.1016/j.intimp.2016.12.022Get rights and content

Highlights

  • Ozone therapy slows down the CKD progression of 5/6 nephrectomized rats.

  • Chronic renal injury is ameliorated by ozone therapy in 5/6 nephrectomized rats.

  • Ozone therapy reduces chronic renal inflammation by modulating NLRP3 inflammasome.

  • Ozone therapy might be a promising reno-protecting treatment for CKD patients.

Abstract

Ozone therapy is an effective medical treatment for various diseases. A previous study has demonstrated its reno-protective effect in chronic kidney disease (CKD), but the mechanism involved is not completely known. This study produced the 5/6 nephrectomized CKD rat model and investigated whether the reno-protective effect of ozone therapy was achieved by its anti-inflammatory property through the modulation of the NLRP3 inflammasome. The results showed that ozone therapy at a low concentration improved renal function and ameliorated renal morphological injury in 5/6 nephrectomized rats. The expression of NLRP3, ASC, and caspase-1-p10 in the kidney of these rats was simultaneously lowered by ozone therapy. Moreover, renal inflammation caused by IL-1β was significantly alleviated by ozone therapy. The Pearson correlation analysis indicated that the protein level of IL-1β was positively correlated with renal injury scores. Taken together, these results indicated that ozone therapy might reduce sterile renal inflammation and slow down CKD progression through the modulation of the NLRP3 inflammasome in 5/6 nephrectomized rats.

Introduction

Progressive chronic kidney disease (CKD), an irreversible disease ending with end-stage renal failure, is induced and gradually aggravated by constant glomerular and tubulointerstitial injuries with a wide spectrum of causes such as diabetes and hypertension [1]. It has caused worldwide concern in public health for many years, and the health burden due to it is still rising [2]. Thus far, despite expensive renal replacement therapy, few cost-effective therapeutic measures have been developed to ameliorate this chronic renal injury and slow down the progression of CKD [3].

Sterile renal inflammation is considered as the central therapeutic target to reduce chronic renal injury and slow down the progression of CKD [4]. This persistent inflammation leads to progressive renal fibrosis and the gradual loss of renal function, which accelerates CKD progression [5]. Nacht domain-, leucine-rich repeat-, and pyrin domain-containing protein 3 (NLRP3) inflammasome is the most well-studied inflammasome that is recognized to play a crucial part in the initiation and continuance of inflammation in various diseases [6]. It is well known that external or internal warning signals can activate the NLRP3 inflammasome via pattern recognition receptor NLRP3. This results in the oligomerization of NLRP3 with the apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), which leads to the proteolytic cleavage of caspase-1. Once cleaved, caspase-1 modulates the maturation of IL-1β and leads to inflammation [7]. The NLRP3 inflammasome alerts the immune system to combat insults, but contributes to pathological injury if constantly activated. The NLRP3 inflammasome has recently aroused great interest among many nephrologists because of its contribution to sterile renal inflammation in CKD [8], [9], [10]. Targeting the NLRP3 inflammasome is therefore a promising strategy to reduce renal inflammation in CKD.

Ozone, a strong oxidant, was once used as a potent gaseous sterilant. Interestingly, modern medicine has proved that proper application of ozone-oxygen mixture at low concentration, also known as ozone therapy, could effectively improve organ ischemia-reperfusion, herniated disks and skin ulcers in the clinic [11], [12], [13]. After being studied for many years, ozone therapy has been applied by many institutes as a beneficial and cost-effective alternative medical measure, and it has become increasingly popular around the world [14], [15]. Emerging evidence indicates that improving the antioxidant system and inducing oxidative-stress adaptation are the main mechanisms for successful ozone therapy in various diseases [16], [17]. Recent advances revealed that ozone therapy could exert an anti-inflammatory action through the regulation of NF-κB in liver ischemia-reperfusion injury and rheumatoid arthritis. In addition, it can ameliorate renal inflammation through the modulation of TLR4 in acute renal ischemia-reperfusion injury [11], [18], [19]. However, it is still unknown whether ozone therapy could exert an anti-inflammatory effect to reduce chronic renal injury in CKD by regulating the NLRP3 inflammasome. Thus, we developed the 5/6 nephrectomized rat model and aimed to address the issue.

Section snippets

Animals and experimental design

Male Sprague-Dawley rats weighing about 180–200 g (8 weeks of age) were obtained from the Animal Experimental Center of Xiangya School of Medicine, Changsha, China. The rats were housed in a room with a stable temperature of 22 °C–23 °C, humidity at 50%–60% and a 12-hour light and dark cycle for 7 days of acclimation. The rats were fed a standard diet, and water was freely available. All the experimental procedures were approved by the Experimental Animal Center Committee in Xiangya School of

Ozone therapy improved renal function

Serum Cr, BUN, K, Ca, and IP were measured to evaluate the renal function of the experimental rats. Compared with the Sham group, the CKD group showed significantly higher Cr, BUN, K, and IP levels (Table 2, P < 0.05) but a slightly lower Ca level (Table 2, P > 0.05). However, the OT group showed significantly lower Cr, BUN, K, and IP levels after ozone therapy, relative to those of the CKD group (Table 2, P < 0.05). But instead of a significant difference, there was only an increasing trend towards

Discussion

The 5/6 nephrectomized rat model is considered as a classic animal model for CKD research. After the surgical operation was performed, the remnant kidney of the experimental rat would suffer high perfusion, high pressure, as well as high filtration, gradually leading to the functional deterioration of residual nephrons. This would result in chronic glomerular and tubulointerstitial injuries. These changes are similar to those found in CKD patients in the clinic [23], [28]. In the present study,

Conclusion

This study first suggested that the reno-protective effect of ozone therapy might be achieved by its anti-inflammatory property through the modulation of the NLRP3 inflammasome in 5/6 nephrectomized rats. Possibly, regulating the NLRP3 inflammasome might account for the inflammation-suppressing effect of ozone therapy in other diseases. Our study, together with some previous ones [29], [51], indicates that ozone therapy, as a promising but neglected treatment, might be a beneficial and

References (51)

  • T. Jiang

    Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-kappaB-mediated inflammatory response

    Kidney Int.

    (2014)
  • C.C. Sun

    Sulforaphane attenuates muscle inflammation in dystrophin-deficient mdx mice via NF-E2-related factor 2 (Nrf2)-mediated inhibition of NF-kappaB signaling pathway

    J. Biol. Chem.

    (2015)
  • P.J. Bakker

    A tissue-specific role for Nlrp3 in tubular epithelial repair after renal ischemia/reperfusion

    Am. J. Pathol.

    (2014)
  • K.S. Hodgkins et al.

    Tubulointerstitial injury and the progression of chronic kidney disease

    Pediatr. Nephrol.

    (2012)
  • H. Guo et al.

    Inflammasomes: mechanism of action, role in disease, and therapeutics

    Nat. Med.

    (2015)
  • G. Lorenz et al.

    Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis

    Nephrol. Dial. Transplant.

    (2014)
  • A. Vilaysane

    The NLRP3 inflammasome promotes renal inflammation and contributes to CKD

    J. Am. Soc. Nephrol.

    (2010)
  • M. Xia

    Characterization and activation of NLRP3 inflammasomes in the renal medulla in mice

    Kidney Blood Press. Res.

    (2016)
  • H.J. Anders et al.

    The inflammasomes in kidney disease

    J. Am. Soc. Nephrol.

    (2011)
  • M. Paoloni

    Intramuscular oxygen-ozone therapy in the treatment of acute back pain with lumbar disc herniation: a multicenter, randomized, double-blind, clinical trial of active and simulated lumbar paravertebral injection

    Spine (Phila Pa 1976)

    (2009)
  • J. Zhang

    Increased growth factors play a role in wound healing promoted by noninvasive oxygen-ozone therapy in diabetic patients with foot ulcers

    Oxidative Med. Cell. Longev.

    (2014)
  • O.S. Leon Fernandez

    Ozone oxidative preconditioning is mediated by A1 adenosine receptors in a rat model of liver ischemia/reperfusion

    Transpl. Int.

    (2008)
  • M. Sagai et al.

    Mechanisms of action involved in ozone therapy: is healing induced via a mild oxidative stress?

    Med. Gas Res.

    (2011)
  • N. Di Paolo et al.

    Extracorporeal blood oxygenation and ozonation: clinical and biological implications of ozone therapy

    Redox Rep.

    (2005)
  • M.D. Morsy et al.

    Improvement of renal oxidative stress markers after ozone administration in diabetic nephropathy in rats

    Diabetol. Metab. Syndr.

    (2010)
  • Cited by (29)

    • Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study

      2021, International Immunopharmacology
      Citation Excerpt :

      The inflammatory response is a hallmark of severe infection and cytokine modulation is key to avoid patient deterioration. Ozone is able to modulate and control cytokines releasing anti-inflammatory cytokines and reducing activity of pro-inflammatory such as IL-1, IL-6 and TNF-α counteracting the state of hyperinflammation seen in COVID patients, but in addition, ozone has potent anti-inflammatory properties through the modulation of the NLRP3 inflammasome which is recognized to play a crucial role in the initiation and continuance of inflammation in various diseases [12]. Ozone may also modulate the accumulation of neutrophils locally, the expression of IL-6, TNF-α, and albumin modified by ischemia in the kidneys, as well as increase local antioxidant capacity [13].

    • Ozone: a natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders

      2020, Ageing Research Reviews
      Citation Excerpt :

      Interestingly, a study reported the benefit effect of O3 on Menière’s disease (Pawlak-Osinska et al., 2004). Moreover, as reported for polyphenols and mushrooms (Hsiao et al., 2016, Ferreiro et al., 2018, Oh et al., 2014, Pan et al., 2018, Hasanzadeh et al., 2020, Wang et al., 2019b), O3 has been found to be involved in β-catenin system (Emon et al., 2017) as well as in NLRP3 (nitrogen permease regulator-like 3) inflammasome (Yu et al., 2017, Wang et al., 2018c). All these evidence support that, as polyphenols and mushrooms, O3 acts in the same direction.

    • Melatonin attenuates airway inflammation via SIRT1 dependent inhibition of NLRP3 inflammasome and IL-1β in rats with COPD

      2018, International Immunopharmacology
      Citation Excerpt :

      The chronic airway inflammation provoked by cigarette smoke contributes to small airway abnormality and parenchymal destruction [3], which is central to the development of COPD. Accumulating studies demonstrated that the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome was implicated in a range of chronic inflammatory diseases [4–6]. NLRP3 inflammasome consists of NLRP3, caspase-1 and apoptosis associated speck-like protein (ASC), which promotes the maturation of proinflammatory cytokine interleukine-1β (IL-1β).

    View all citing articles on Scopus
    View full text